These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10379462)

  • 1. Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum.
    Langman MJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S2-5. PubMed ID: 10379462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study.
    Dib RA; Chinzon D; Fontes LH; de Sá Teixeira AC; Navarro-Rodriguez T
    Scand J Gastroenterol; 2014 Jul; 49(7):785-9. PubMed ID: 24941264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.
    Hansen JM; Hallas J; Lauritsen JM; Bytzer P
    Scand J Gastroenterol; 1996 Feb; 31(2):126-30. PubMed ID: 8658033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcer complications and nonsteroidal anti-inflammatory drugs.
    Langman MJ
    Am J Med; 1988 Feb; 84(2A):15-9. PubMed ID: 3348238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials.
    Boers M; Tangelder MJ; van Ingen H; Fort JG; Goldstein JL
    Ann Rheum Dis; 2007 Mar; 66(3):417-8. PubMed ID: 16887862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].
    Dobrilla G; Benvenuti S; de Guelmi A
    Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan.
    Ishikawa S; Inaba T; Mizuno M; Okada H; Kuwaki K; Kuzume T; Yokota H; Fukuda Y; Takeda K; Nagano H; Wato M; Kawai K
    Acta Med Okayama; 2008 Feb; 62(1):29-36. PubMed ID: 18323869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drug-induced gastric damage: epidemiology.
    Shorrock CJ; Langman MJ
    Dig Dis; 1995 Jan; 13 Suppl 1():3-8. PubMed ID: 7697900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
    Chen TS; Luo JC; Chang FY
    J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of non-steroidal anti-inflammatory drugs associated gastroduodenal ulcer bleeding].
    Zhang L; Lu YM; Ding SG; Liao ZL
    Zhonghua Nei Ke Za Zhi; 2003 Apr; 42(4):258-60. PubMed ID: 12887811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
    García Rodríguez LA; Barreales Tolosa L
    Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of NSAID-induced ulcers in the elderly.
    Geriatrics; 2005 Oct; Suppl():3-12; quiz 13-4. PubMed ID: 16334635
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk factors for upper digestive tract toxicity with NSAIDs (excluding Helicobacter pylori)].
    Lamarque D; Chaussade S
    Presse Med; 2003 Nov; 32(37 Pt 2):S56-9. PubMed ID: 14763357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
    Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons.
    Smalley WE; Ray WA; Daugherty JR; Griffin MR
    Am J Epidemiol; 1995 Mar; 141(6):539-45. PubMed ID: 7900721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE; Nasonova VA
    Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
    Publig W; Wüstinger C; Zandl C
    Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological aspects of NSAID gastropathy.
    Guslandi M
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():6-8. PubMed ID: 9032573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.